Navigation Links
Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting
Date:11/14/2011

first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, and also affects a number of other key signal transduction pathways, including the JNK pathway, all of which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 3 clinical development for both refractory advanced colorectal cancer and multiple myeloma, and in Phase 1 and 2 clinical development for several other tumor types. Each of the KRX-0401 Phase 3 studies is being conducted under a Special Protocol Assessment (SPA) agreement with the FDA. Keryx is also developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of Zerenex for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is being conducted pursuant to an SPA agreement with the FDA. Keryx is headquartered in New York City.

Cautionary Statement
Some of the statements included in this press release, particularly those anticipating the outcome of clinical trials and the future business prospects for Zerenex (ferric citrate), may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: our ability to successfully complete clinical trials for Zerenex; our ability to meet anticipated development timelines for Zerenex due to clinical trial results, manufacturing capabilities or other factors; our ability to replicate in our ongoing long-term Phase 3 clinical study the efficacy and safety of Zerenex observed in the previous Phase 2 studies and the short-te
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at Lazard Capital Markets 8th Annual Healthcare Conference
2. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
3. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results
4. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
5. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financial Results
7. Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering
8. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
9. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2010 Financial Results
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year End 2010 Financial Results on Wednesday, March 9, 2011 at 8:30 a.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Nektar Therapeutics (NASDAQ: ... today announced positive results from its Phase 3 ... extended half-life recombinant factor VIII (rFVIII) treatment for ... which met its primary endpoint in reducing annualized ... to the on-demand arm. Top-line results ...
(Date:8/21/2014)... Canadian Epilepsy Alliance (CEA) is thrilled to announce the launch ... the most common neurological disorder in Canada ... tells a fictional story based on the experiences of 14-year-old ... "Despite the fact that epilepsy affects 1 ... lack of awareness out there," says Gail Dempsey , ...
(Date:8/21/2014)... percent of Americans believe the abuse of strong prescription pain ... safety issue in the United States , ... & Partners, a Cincinnati based research ... the prescription medication abuse problem and the need for medical ... facing our country," Rex Repass , CEO of the ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... 2011 ORTHOCON, Inc., a privately-held therapeutic device ... worldwide license agreement with Bezwada Biomedical to develop ... Bezwada Biomedical is an innovation-driven company ... biocompatible polyurethanes and polyamides derived from hydrolyzable isocyanates. ...
... Caliper Life Sciences, Inc. (NASDAQ: CALP ... Spectrum CT , a breakthrough preclinical imaging system that ... and low dose microCT (micro computed tomography).  Spectrum CT ... with vital, unparalleled insights into complex biological systems in ...
Cached Medicine Technology:ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical 2Caliper Life Sciences Announces IVIS Spectrum CT 2Caliper Life Sciences Announces IVIS Spectrum CT 3
(Date:8/22/2014)... Yountville, CA (PRWEB) August 22, 2014 Tug ... White and Blue (Team RWB) to participate in the 39th ... athletes and Team McGraw runners will join forces in coaching, ... the most significant highlights of our nation's capital and is ... Begun in 1975, the Marine Corps Marathon is the largest ...
(Date:8/22/2014)... California (PRWEB) August 22, 2014 The ... , BillionaireFish.com, recently registered its two millionth member, and ... threshold. , Billionairefish.com is a dating website for ... women to date. The dating website caters like-minded people ... dating site for the rich , this is ...
(Date:8/22/2014)... 22, 2014 The Berkowitz Law Firm ... a client who suffered severe, permanent injuries in an ... driver (docket number FST-CV13-6018309-S). The case was pending in ... According to Jennifer Amdur of The Berkowitz Law Firm ... all of whom were allegedly injured following ...
(Date:8/22/2014)... Reacting to naysayers who are being skeptical about ... top PRP therapy LA specialist has firmly stated that ... with practical well researched science and nothing to do ... new medical breakthrough technology which focuses on healing and ... therapy. , The Managing Director of one of the ...
(Date:8/22/2014)... 2014 The rising numbers of teen drug ... in Asheville, NC. For many years, countless lives have been ... difference in the community a new helpline was established to ... in North Carolina who are seeking to overcome their addiction ... at (828) 348-5762, parents and their teens can speak immediately ...
Breaking Medicine News(10 mins):Health News:Tug McGraw Foundation and Team Red White and Blue Join to Run in Marine Corps Marathon 2Health News:Tug McGraw Foundation and Team Red White and Blue Join to Run in Marine Corps Marathon 3Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 2Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 3Health News:The Berkowitz Law Firm LLC Reaches a $2 Million Settlement for a Client Allegedly Injured in Drunk Driving Accident 2Health News:MetroMD With The Help Of PRP Therapy Helps People Fight Hip Injuries 2Health News:Troubled Teens in Asheville, NC Turn to Helpline for Valuable Assistance 2
... Bertalan Mesko, medical blogger and health 2.0 consultant, ... medical and scientific videos and animations. This list ... best quality. Some of the sites are created for ... focusing on health issues, while others were designed primarily ...
... who,d been tormented, , , FRIDAY, May 8 (HealthDay News) ... younger are more likely than others their age to ... report. , Their study involved 6,437 youths, who averaged ... provided regular updates about the youngsters, health and development ...
... CDC report shows 11 cases of similar strain since 2005 ... puzzled as to the roots of the swine flu outbreak currently ... U.S. Centers for Disease Control and Prevention and released online Thursday ... 11 cases of infection with a swine flu virus similar to ...
... May 8 The majority of uninsured American families ... an employer cannot afford to buy health insurance, according ... Research and Quality.Some experts have suggested that because 23.8 ... have access to employer-based health insurance have incomes above ...
... WINNIPEG, May 8 /PRNewswire/ - Kevin McGarry, Chairman of ... Systems), announces the appointment of Dr. Niels Erik Hansen ... to the appointment of Dr Hansen, Mr. McGarry held ... Chief Executive Officer and stewarded its evolution from a ...
... Pregnancy (MiP) Consortium, led by the Liverpool School of ... European and Developing Countries Clinical Trials Partnership (EDCTP) to ... The three grant recipients the Liverpool School ... Research in Spain and the Prince Leopold Institute of ...
Cached Medicine News:Health News:Bullying Seems to Affect Kids Years Later 2Health News:Scientists Still Baffled About Origins of Swine Flu 2Health News:Scientists Still Baffled About Origins of Swine Flu 3Health News:Scientists Still Baffled About Origins of Swine Flu 4Health News:New Study Finds Fewer Families Can Afford Health Insurance 2Health News:MiP Consortium awarded €11 million by EDCTP 2Health News:MiP Consortium awarded €11 million by EDCTP 3
... broad selection of tip styles for ... ophthalmic procedures. Each single use cautery ... safety cap to lock switch in ... in use, and carries a 3-4 ...
... Accu-Temp Cauteries provide a broad ... in a wide variety of ophthalmic ... packaged sterile, complete with a safety ... "off " position when not in ...
... Probes provide the surgeon with an indirect ... to be easily visualized through the laser ... and light scatter technique, the surgeon can ... flap edge folds, corneal flap striae and ...
... The B-VAT® PC visual acuity system allows ... of the B-VAT II. The system includes ... contrast sensitivity testing and animated characters. Random ... operator has single letter, single line and ...
Medicine Products: